Australia Holds Fast on Hep B Vaccine Guidelines Despite US Shifts

Australian parents can safely maintain confidence in the national childhood immunisation schedule, according to Hepatitis Australia, even as the United States significantly overhauls its own approach to hepatitis B vaccination by shifting to individual risk assessments and shared clinical decision-making. Australia Holds Firm on Evidence-Based Hepatitis B Vaccination Schedule Hepatitis Australia insists that Australia’s medical … Read more

Natural Hormone Suppresses Liver Inflammation via Brain-Gut Pathway

According to researchers at McMaster University, the naturally occurring hormone GDF15 protects the liver from inflammation and slows the progression of scarring through a brain-to-liver signaling pathway independent of weight loss. Published in Cell Metabolism, the findings challenge longstanding assumptions about the hormone, which is best known for suppressing appetite and promoting weight loss. Understanding … Read more

Daily Tomatoes Reduce Liver Fat in MASLD Trial

Daily consumption of raw tomatoes and tomato sauce significantly reduces controlled attenuation parameter (CAP)-defined hepatic steatosis in adults with metabolic dysfunction-associated steatotic liver disease (MASLD), according to an exploratory randomized controlled trial published in the journal Nutrients. Researchers found that a six-week tomato-rich diet outperformed a tomato-free control group, dropping median CAP values by 35 … Read more

Chronotype and Liver Health: No Significant Link Found

A recent cross-sectional study published in the journal Nutrients found no statistically significant link between an individual’s chronotype—their natural preference for morning or evening activity—and the presence of liver fat or fibrosis in adults with overweight or obesity. Researchers at the National Institute of Gastroenterology in Italy assessed 119 medication-naïve participants using the Morningness–Eveningness Questionnaire … Read more

Mexico Must Prioritize Liver Disease in Chronic Care: Expert Recommendations

Metabolic dysfunction-associated steatotic liver disease (MASLD) may affect up to 47% of adults in Mexico, according to a review published in Archives of Medical Research. Lead author Jeffrey Lazarus, a professor at the CUNY Graduate School of Public Health and Health Policy, argues that Mexico must integrate liver health into existing obesity and diabetes programs … Read more

New Ultrasensitive Biosensor Detects Early-Stage Liver Fibrosis via Blood Test

Researchers at Sungkyunkwan University (SKKU), in collaboration with the Catholic University of Korea and Eunpyeong St. Mary’s Hospital, have developed an ultrasensitive electrochemical biosensor capable of detecting early-stage liver fibrosis through a small blood sample. The device, known as FIB-EIS, identifies the protein PICP to signal liver hardening, potentially replacing invasive tissue biopsies with a … Read more

Ireland Urged to Recognize ‘Hidden Condition’ Symptoms

The “Celtic Gene”: Why Early Detection is Transforming Ireland’s Health Landscape Haemochromatosis, often dubbed the “Celtic Gene,” is a silent health crisis hiding in plain sight. As Ireland’s most common genetic condition, it affects a staggering number of people, yet it remains frequently overlooked by both patients and healthcare providers. With approximately 1 in 83 … Read more

New Oral Drug Boosts Platelet Recovery in GI Cancer Patients

Breaking Barriers in Cancer Care: Oral Medication Shows Promise for Chemotherapy Side Effects For patients battling gastrointestinal cancers, the journey through chemotherapy is often interrupted by a common but debilitating obstacle: chemotherapy-induced thrombocytopenia (CIT). This condition, characterized by low blood platelet counts, often forces clinicians to delay or reduce life-saving treatment doses, which can negatively … Read more

Paxlovid speeds recovery but does not reduce severe COVID outcomes in vaccinated adults

The Evolution of COVID-19 Treatment: From Broad Application to Precision Care The landscape of antiviral treatment is shifting. For years, the primary goal of early intervention with Paxlovid (nirmatrelvir-ritonavir) was the prevention of severe outcomes, such as hospitalization and death. However, as vaccination rates have climbed, the clinical utility of these treatments is evolving. View … Read more